Catalyst Wire Dossier Catalyst Wire Dossier

Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions

ipratropium and levosalbutamol free-dose combination · Neutec Ar-Ge San ve Tic A.Ş
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions, covering 2023-09-05 to 2023-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

See pricing